Cargando…
Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice
BACKGROUND: Hepatocellular carcinoma (HCC) is a primary liver tumor and is the most difficult human malignancy to treat. In this study, we sought to develop an integrative approach in which real-time tumor monitoring, gene therapy, and internal radiotherapy can be performed simultaneously. This was...
Autores principales: | Chen, Jing, Zhu, Shu, Tong, Liangqian, Li, Jiansha, Chen, Fei, Han, Yunfeng, Zhao, Ming, Xiong, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938316/ https://www.ncbi.nlm.nih.gov/pubmed/24555445 http://dx.doi.org/10.1186/1471-2407-14-114 |
Ejemplares similares
-
Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy
por: Yang, Zhen, et al.
Publicado: (2018) -
Short and Long-Term Effects of hVEGF-A(165) in Cre-Activated Transgenic Mice
por: Leppänen, Pia, et al.
Publicado: (2006) -
Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles
por: Castillo, Betzaida, et al.
Publicado: (2012) -
Hypoxic response elements and Tet-On advanced double-controlled systems regulate hVEGF(165) and angiopoietin-1 gene expression in vitro()
por: Zhang, Hao, et al.
Publicado: (2011) -
Inhibition of lung tumor growth in nude mice by siRNA(CD31) targeting PECAM-1
por: OUYANG, JIN-SHENG, et al.
Publicado: (2014)